Skip to main content
. 2021 Mar 29;9(3):335–344. doi: 10.14218/JCTH.2020.00164

Fig. 5. Pooled OR of virological response in TDF+ETV-treated vs. TDF-treated CHB patients after 48 weeks of treatment.

Fig. 5

CHB, chronic hepatitis B; ETV, entecavir; OR, odds ratio; TDF, tenofovir disoproxil fumarate.